Quantcast

Latest Factor XIII deficiency Stories

2011-02-23 10:50:00

PRINCETON, N.J., Feb. 23, 2011 /PRNewswire/ -- Novo Nordisk announced today that a Biologic License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of a recombinant factor XIII compound (rFXIII) for the vast majority of patients with congenital factor XIII (FXIII) deficiency, an inherited bleeding disorder(1). The company anticipates filing its marketing authorization application to the European Medicines Agency in Q2 2011....

2011-02-17 13:49:00

Corifact is 1st treatment for congenital Factor XIII Deficiency SILVER SPRING, Md., Feb. 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Patients with congenital Factor XIII deficiency don't make enough Factor XIII, a substance that circulates in the blood...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related